-
1
-
-
77958461205
-
Carotid plaque formation and serum biomarkers
-
Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis 2010;213:21-29
-
(2010)
Atherosclerosis
, vol.213
, pp. 21-29
-
-
Hermus, L.1
Lefrandt, J.D.2
Tio, R.A.3
Breek, J.C.4
Zeebregts, C.J.5
-
2
-
-
80053974064
-
Symptomatic and asymptomatic carotid artery plaque
-
MughalMM, Khan MK,DeMarco JK, Majid A, Shamoun F, Abela GS. Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther 2011;9:1315-1330
-
(2011)
Expert Rev Cardiovasc Ther
, vol.9
, pp. 1315-1330
-
-
Mughal, M.M.1
Khan, M.K.2
De Marco, J.K.3
Majid, A.4
Shamoun, F.5
Abela, G.S.6
-
3
-
-
33644680768
-
The vulnerable carotid artery plaque: Current imaging methods and new perspectives
-
Nighoghossian N, Derex L, Douek P. The vulnerable carotid artery plaque: Current imaging methods and new perspectives. Stroke 2005;36:2764-2772
-
(2005)
Stroke
, vol.36
, pp. 2764-2772
-
-
Nighoghossian, N.1
Derex, L.2
Douek, P.3
-
4
-
-
44449125709
-
The role of AGEs in cardiovascular disease
-
Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des 2008;14:979-986
-
(2008)
Curr Pharm Des
, vol.14
, pp. 979-986
-
-
Jandeleit-Dahm, K.1
Cooper, M.E.2
-
5
-
-
4043058031
-
Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in Diabetes
-
Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in Diabetes. Cardiovasc Res 2004;63:582-592
-
(2004)
Cardiovasc Res
, vol.63
, pp. 582-592
-
-
Basta, G.1
Schmidt, A.M.2
De Caterina, R.3
-
6
-
-
84900001245
-
Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype
-
Hanssen NMJ, Wouters K, Huijberts MS, Gijbels MJ, Sluimer JC, Scheijen JLJM, Heeneman S, Biessen EAL, Daemen MJAP, Brownlee M, de Kleiijn DP, Stehouwer CDA, Pasterkamp G, Schalkwijk CG. Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype. Eur Heart J 2014;35:1137-1146
-
(2014)
Eur Heart J
, vol.35
, pp. 1137-1146
-
-
Hanssen, N.M.J.1
Wouters, K.2
Huijberts, M.S.3
Gijbels, M.J.4
Sluimer, J.C.5
Scheijen, J.L.J.M.6
Heeneman, S.7
Biessen, E.A.L.8
Daemen, M.J.A.P.9
Brownlee, M.10
De Kleiijn, D.P.11
Stehouwer, C.D.A.12
Pasterkamp, G.13
Schalkwijk, C.G.14
-
7
-
-
0037062656
-
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography
-
Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnstrom P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD,Weissberg PL. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-2711
-
(2002)
Circulation
, vol.105
, pp. 2708-2711
-
-
Rudd, J.H.1
Warburton, E.A.2
Fryer, T.D.3
Jones, H.A.4
Clark, J.C.5
Antoun, N.6
Johnstrom, P.7
Davenport, A.P.8
Kirkpatrick, P.J.9
Arch, B.N.10
Pickard, J.D.11
Weissberg, P.L.12
-
8
-
-
84856729229
-
Protection against methylglyoxal-derived ages by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology
-
Berner AK, Brouwers O, Pringle R, Klaassen I, Colhoun L, McVicar C, Brockbank S, Curry JW, Miyata T, Brownlee M, Schlingemann RO, Schalkwijk C, Stitt AW. Protection against methylglyoxal-derived ages by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Diabetologia 2012;55:845-854
-
(2012)
Diabetologia
, vol.55
, pp. 845-854
-
-
Berner, A.K.1
Brouwers, O.2
Pringle, R.3
Klaassen, I.4
Colhoun, L.5
McVicar, C.6
Brockbank, S.7
Curry, J.W.8
Miyata, T.9
Brownlee, M.10
Schlingemann, R.O.11
Schalkwijk, C.12
Stitt, A.W.13
-
9
-
-
67649732476
-
Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: The Hoorn and CoDAM studies
-
Engelen L, Ferreira I, Brouwers O, Henry RM, Dekker JM, Nijpels G, Heine RJ, van Greevenbroek MM, van Der Kallen CJ, Blaak EE, Feskens EJ, ten Cate H, Stehouwer CD, Schalkwijk CG. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: The Hoorn and CoDAM studies. J Hypertens 2009;27:1399-1403
-
(2009)
J Hypertens
, vol.27
, pp. 1399-1403
-
-
Engelen, L.1
Ferreira, I.2
Brouwers, O.3
Henry, R.M.4
Dekker, J.M.5
Nijpels, G.6
Heine, R.J.7
Van Greevenbroek, M.M.8
Van Der Kallen, C.J.9
Blaak, E.E.10
Feskens, E.J.11
Ten Cate, H.12
Stehouwer, C.D.13
Schalkwijk, C.G.14
-
10
-
-
77950898257
-
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
-
Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 2010;106:842-853
-
(2010)
Circ Res
, vol.106
, pp. 842-853
-
-
Yan, S.F.1
Ramasamy, R.2
Schmidt, A.M.3
-
11
-
-
84872130535
-
Anti-inflammatory therapy in chronic disease: Challenges and opportunities
-
Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: Challenges and opportunities. Science 2013;339:166-172
-
(2013)
Science
, vol.339
, pp. 166-172
-
-
Tabas, I.1
Glass, C.K.2
-
12
-
-
0035949502
-
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker
-
Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001;104:1464-1470
-
(2001)
Circulation
, vol.104
, pp. 1464-1470
-
-
Kass, D.A.1
Shapiro, E.P.2
Kawaguchi, M.3
Capriotti, A.R.4
Scuteri, A.5
De Groof, R.C.6
Lakatta, E.G.7
-
13
-
-
33845295849
-
Benfotiamine prevents macro- And microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes
-
Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Gotting C, Kleesiek K, Mueller-Roesel M, KoschinskyT, Uribarri J, Vlassara H, Tschoepe D. Benfotiamine prevents macro- And microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care 2006;29:2064-2071
-
(2006)
Diabetes Care
, vol.29
, pp. 2064-2071
-
-
Stirban, A.1
Negrean, M.2
Stratmann, B.3
Gawlowski, T.4
Horstmann, T.5
Gotting, C.6
Kleesiek, K.7
Mueller-Roesel, M.8
Koschinsky, T.9
Uribarri, J.10
Vlassara, H.11
Tschoepe, D.12
-
14
-
-
51249107520
-
Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes
-
Du X, Edelstein D, Brownlee M. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 2008;51:1930-1932
-
(2008)
Diabetologia
, vol.51
, pp. 1930-1932
-
-
Du, X.1
Edelstein, D.2
Brownlee, M.3
-
15
-
-
4143113592
-
Simple non-invasive assessment of advanced glycation endproduct accumulation
-
Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, BaynesJW, Gans RO, Smit AJ. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330
-
(2004)
Diabetologia
, vol.47
, pp. 1324-1330
-
-
Meerwaldt, R.1
Graaff, R.2
Oomen, P.H.3
Links, T.P.4
Jager, J.J.5
Alderson, N.L.6
Thorpe, S.R.7
Baynes, J.W.8
Gans, R.O.9
Smit, A.J.10
|